control group:Radiotherapy alone

2 trials

Sponsors

Jiangxi Cancer Hospital, Xi'an Jiaotong University Second Affiliated Hospital

Conditions

Lung cancerNasopharyngeal carcinoma

Phase 3

A multicenter, prospective, randomized controlled study of radiotherapy combined with teriprizumab versus radiotherapy alone in the treatment of elderly patients with locally advanced nasopharyngeal carcinoma

RecruitingChiCTR2100051031

Jiangxi Cancer HospitalNasopharyngeal carcinoma

Start: 2021-09-15Updated: 2022-05-16

Unknown Phase

Efficacy and Safety of Evolocumab as a Radiosensitizer in Locally Advanced Lung Cancer: A Single-Center, Open-Label, Randomized Controlled Trial

Active, not recruitingChiCTR2600121237

Xi'an Jiaotong University Second Affiliated HospitalLung cancer

Start: 2026-04-01Updated: 2026-03-30